Literature DB >> 24732390

Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care.

Qingli Zhang1, Noni E MacDonald, Jennifer C Smith, Kang Cai, Huiju Yu, Huajun Li, Chuene Lei.   

Abstract

BACKGROUND: Severe outbreaks of enterovirus 71 (EV71) have been on the rise in the Western Pacific region, including in China since 2007. We describe features of pediatric patients admitted with severe disease EV71 to a tertiary care hospital during the 2010 ongoing outbreak in the Shanghai region.
METHODS: The Shanghai EV71 outbreak was studied prospectively from January 2010 to December 2012. To be eligible, children had to be 1 month to <14 years of age, admitted with confirmed EV71 infection to Xinhua Hospital and have severe illness needing Pediatric Infectious Diseases Service care with symptoms/signs of high prolonged fever and/or very unwell general appearance and/or neurological findings but no underlying medical condition. Clinical, laboratory, treatment discharge and follow-up data were recorded and analyzed.
RESULTS: Of 26, 829 children presenting with possible EV71 disease, 2.9% (767) were admitted, more from less developed areas than from Shanghai proper. Of these, 29.2% (224) had severe enough EV71 for study enrolment, 4 excluded for underlying disease. Of 220 enrolled, 40.5% (89) had neurological involvement, 10.5% (23) needed pediatric intensive care unit care and 3% (7) died. Factors associated with severe disease were young age, male gender, high white count, prolonged high fever, high glucose, high C-reactive protein and neurological findings. The majority with neurological involvement and all who died were from the countryside. Early intravenous gamma globulin intervention had better survival. No survivor had persistent sequelae 2 months after discharge.
CONCLUSIONS: This study confirms the morbidity for EV71 disease in China, especially for patients from the countryside versus Shanghai proper. The potential impact of public education, an EV71 vaccine, and the potential benefits versus harms of IVIG treatment are discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24732390     DOI: 10.1097/INF.0000000000000194

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

Review 1.  Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-06       Impact factor: 3.267

2.  Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A.

Authors:  Qianqian Gao; Shilin Yuan; Chao Zhang; Ying Wang; Yizhuo Wang; Guimei He; Shuyi Zhang; Ralf Altmeyer; Gang Zou
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

3.  Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.

Authors:  Shiyang Sun; Liping Jiang; Zhenglun Liang; Qunying Mao; Weiheng Su; Huafei Zhang; Xiaojun Li; Jun Jin; Lin Xu; Dandan Zhao; Peihu Fan; Dong An; Ping Yang; Jingcai Lu; Xiuping Lv; Bo Sun; Fei Xu; Wei Kong; Chunlai Jiang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Association of CD14 rs2569190 G/A genetic polymorphism with the severity of enterovirus 71 infection in Chinese children.

Authors:  Ya Guo; Yedan Liu; Jie Song; Peipei Liu; Sifei Wu; Yuxia Tan; Fan Fan; Zongbo Chen
Journal:  Virology       Date:  2020-06-07       Impact factor: 3.616

5.  Relationship between serologic response and clinical symptoms in children with enterovirus 71-infected hand-foot-mouth disease.

Authors:  Jun Shen; Chao Zhao; Ping Cao; Peng Shi; Lingfeng Cao; Qirong Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  In Vitro Assessment of Combinations of Enterovirus Inhibitors against Enterovirus 71.

Authors:  Yizhuo Wang; Guiming Li; Shilin Yuan; Qianqian Gao; Ke Lan; Ralf Altmeyer; Gang Zou
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.938

7.  Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis.

Authors:  Ying Wang; Gang Zou; Aimei Xia; Xiangshi Wang; Jiehao Cai; Qianqian Gao; Shilin Yuan; Guimei He; Shuyi Zhang; Mei Zeng; Ralf Altmeyer
Journal:  Virol J       Date:  2015-06-03       Impact factor: 4.099

8.  Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway.

Authors:  Issac Horng Khit Too; Huimin Yeo; October Michael Sessions; Benedict Yan; Eshele Anak Libau; Josephine L C Howe; Ze Qin Lim; Shalini Suku-Maran; Wei-Yi Ong; Kaw Bing Chua; Boon Seng Wong; Vincent T K Chow; Sylvie Alonso
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

9.  The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection.

Authors:  Xuyuan Zhang; Pan Yang; Nan Wang; Jialong Zhang; Jingyun Li; Hao Guo; Xiangyun Yin; Zihe Rao; Xiangxi Wang; Liguo Zhang
Journal:  Protein Cell       Date:  2017-04-26       Impact factor: 14.870

10.  Enterovirus A71 Infection and Neurologic Disease, Madrid, Spain, 2016.

Authors:  Carmen Niño Taravilla; Isabel Pérez-Sebastián; Alberto García Salido; Claudia Varela Serrano; Verónica Cantarín Extremera; Anna Duat Rodríguez; Laura López Marín; Mercedes Alonso Sanz; Olga María Suárez Traba; Ana Serrano González
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.